| Company Name | # of Hedge Funds | # of Insiders Buying | # of Insiders Selling |
| ShangPharma Corp (ADR) (NYSE:SHP) | 6 | 0 | 0 |
| ArQule, Inc. (NASDAQ:ARQL) | 13 | 0 | 0 |
| OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) | 4 | 0 | 0 |
| Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) | 10 | 0 | 0 |
| Durata Therapeutics Inc (NASDAQ:DRTX) | 5 | 7 | 0 |
With the results exhibited by the aforementioned strategies, retail investors should always monitor hedge fund and insider trading activity, and Cytokinetics, Inc. (NASDAQ:CYTK) applies perfectly to this mantra.
